APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Clinical Trial Supplies

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.

Selected research

Market Outlook & Growth Opportunities

Global Clinical Trial Supplies Market Outlook and Growth Opportunities 2026

Report ID 173900910428 December 2025193 pages

Choose your research edition.

Industry ResearchClinical Trial Supplies Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Trial Supplies Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Clinical Trial Supplies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Trial Supplies Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Trial Supplies Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.

Safe clinical trials are premised on strong supply chain management of the investigational drug, in accordance with regional and global regulations, and in line with local production and development realities. Clinical trial consumable management is critical to avoid overproduction, inventory expiration, and oversupply.As the cost of drug development continues to rise, the supply of clinical trials is becoming ever more important.In addition, strict operational requirements for the implementation of a variety of biopharmaceutical products into clinical trials require constant reform of clinical trial supply strategies.This also requires the integration of multiple third party vendors at all stages of clinical development. Global Clinical Trial Supplies key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare etc. China top five manufacturers hold a Production Share over 70%. North America accounts for the most Sales Market Share, which have a share over 50%, followed by Europe. In terms of product, Supply Chain Management is the largest segment, with a Market Share over 35%. And in terms of application, the largest Application is Clinical Phase iii.

This report provides an overview of the global Clinical Trial Supplies market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Clinical Trial Supplies and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Clinical Trial Supplies revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Clinical Trial Supplies market.

Clinical Trial Supplies Segment by Company

Thermo Fisher Scientific

Catalent Pharma Solutions

Almac Group

Parexel International

UDG Healthcare

PCI Services

Marken

Clinical Trial Supplies Segment by Type

Logistics & Distribution

Manufacturing and Packaging

Supply Chain Management

Other

Clinical Trial Supplies Segment by Application

Phase I

Phase II

Phase III

Other

Clinical Trial Supplies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Clinical Trial Supplies status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Clinical Trial Supplies key companies, revenue, market share, and recent developments.

3. To split the Clinical Trial Supplies breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Clinical Trial Supplies market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Clinical Trial Supplies significant trends, drivers, influence factors in global and regions.

6. To analyze Clinical Trial Supplies competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Supplies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Supplies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Supplies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trial Supplies industry.

Chapter 3: Detailed analysis of Clinical Trial Supplies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Clinical Trial Supplies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Clinical Trial Supplies in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Clinical Trial Supplies Industry Trends Table 2. Clinical Trial Supplies Industry Drivers Table 3. Clinical Trial Supplies Industry Opportunities and Challenges Table 4. Clinical Trial Supplies Industry Restraints Table 5. Global Clinical Trial Supplies Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Clinical Trial Supplies Revenue Share by Company (2021-2026) Table 7. Global Clinical Trial Supplies Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Clinical Trial Supplies Key Company Manufacturing Base & Headquarters Table 9. Global Clinical Trial Supplies Company, Product Type & Application Table 10. Global Clinical Trial Supplies Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Clinical Trial Supplies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Logistics & Distribution Table 15. Significant Companies of Manufacturing and Packaging Table 16. Significant Companies of Supply Chain Management Table 17. Significant Companies of Other Table 18. Global Clinical Trial Supplies Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Clinical Trial Supplies Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Clinical Trial Supplies Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Clinical Trial Supplies Sales Value Share by Type (2021-2026) Table 22. Global Clinical Trial Supplies Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Phase I Table 24. Significant Companies of Phase II Table 25. Significant Companies of Phase III Table 26. Significant Companies of Other Table 27. Global Clinical Trial Supplies Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Clinical Trial Supplies Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Clinical Trial Supplies Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Clinical Trial Supplies Sales Value Share by Application (2021-2026) Table 31. Global Clinical Trial Supplies Sales Value Share by Application (2027-2032) Table 32. Global Clinical Trial Supplies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Clinical Trial Supplies Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Clinical Trial Supplies Sales Value Share by Region (2021-2026) Table 35. Global Clinical Trial Supplies Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Clinical Trial Supplies Sales Value Share by Region (2027-2032) Table 37. Global Clinical Trial Supplies Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Clinical Trial Supplies Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Clinical Trial Supplies Sales Value Market Share by Country (2021-2026) Table 40. Global Clinical Trial Supplies Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Clinical Trial Supplies Sales Value Market Share by Country (2027-2032) Table 42. Thermo Fisher Scientific Company Information Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Thermo Fisher Scientific Clinical Trial Supplies Product Portfolio Table 46. Thermo Fisher Scientific Recent Development Table 47. Catalent Pharma Solutions Company Information Table 48. Catalent Pharma Solutions Business Overview Table 49. Catalent Pharma Solutions Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Catalent Pharma Solutions Clinical Trial Supplies Product Portfolio Table 51. Catalent Pharma Solutions Recent Development Table 52. Almac Group Company Information Table 53. Almac Group Business Overview Table 54. Almac Group Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Almac Group Clinical Trial Supplies Product Portfolio Table 56. Almac Group Recent Development Table 57. Parexel International Company Information Table 58. Parexel International Business Overview Table 59. Parexel International Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Parexel International Clinical Trial Supplies Product Portfolio Table 61. Parexel International Recent Development Table 62. UDG Healthcare Company Information Table 63. UDG Healthcare Business Overview Table 64. UDG Healthcare Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. UDG Healthcare Clinical Trial Supplies Product Portfolio Table 66. UDG Healthcare Recent Development Table 67. PCI Services Company Information Table 68. PCI Services Business Overview Table 69. PCI Services Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. PCI Services Clinical Trial Supplies Product Portfolio Table 71. PCI Services Recent Development Table 72. Marken Company Information Table 73. Marken Business Overview Table 74. Marken Clinical Trial Supplies Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Marken Clinical Trial Supplies Product Portfolio Table 76. Marken Recent Development Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Clinical Trial Supplies Product Image Figure 2. Global Clinical Trial Supplies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Trial Supplies Market Size (2021-2032) & (US$ Million) Figure 4. Global Clinical Trial Supplies Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Logistics & Distribution Image Figure 8. Manufacturing and Packaging Image Figure 9. Supply Chain Management Image Figure 10. Other Image Figure 11. Global Clinical Trial Supplies Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Clinical Trial Supplies Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Clinical Trial Supplies Sales Value Share by Type (2021-2032) Figure 14. Phase I Image Figure 15. Phase II Image Figure 16. Phase III Image Figure 17. Other Image Figure 18. Global Clinical Trial Supplies Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Clinical Trial Supplies Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Clinical Trial Supplies Sales Value Share by Application (2021-2032) Figure 21. Global Clinical Trial Supplies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Clinical Trial Supplies Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Clinical Trial Supplies Sales Value (2021-2032) & (US$ Million) Figure 24. North America Clinical Trial Supplies Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Clinical Trial Supplies Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Clinical Trial Supplies Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Clinical Trial Supplies Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Clinical Trial Supplies Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Clinical Trial Supplies Sales Value (2021-2032) & (US$ Million) Figure 30. South America Clinical Trial Supplies Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Clinical Trial Supplies Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Clinical Trial Supplies Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Clinical Trial Supplies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Logistics & Distribution
  • Manufacturing and Packaging
  • Supply Chain Management
  • Other
Applications
  • Phase I
  • Phase II
  • Phase III
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Clinical Trial Supplies Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Clinical Trial Supplies Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Clinical Trial Supplies Market Dynamics
  1. 2.1 Clinical Trial Supplies Industry Trends
  2. 2.2 Clinical Trial Supplies Industry Drivers
  3. 2.3 Clinical Trial Supplies Industry Opportunities and Challenges
  4. 2.4 Clinical Trial Supplies Industry Restraints
3 Clinical Trial Supplies Market by Company
  1. 3.1 Global Clinical Trial Supplies Company Revenue Ranking in 2025
  2. 3.2 Global Clinical Trial Supplies Revenue by Company (2021-2026)
  3. 3.3 Global Clinical Trial Supplies Company Ranking (2024-2026)
  4. 3.4 Global Clinical Trial Supplies Company Manufacturing Base and Headquarters
  5. 3.5 Global Clinical Trial Supplies Company Product Type and Application
  6. 3.6 Global Clinical Trial Supplies Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Clinical Trial Supplies Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Clinical Trial Supplies Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Clinical Trial Supplies Market by Type
  1. 4.1 Clinical Trial Supplies Type Introduction
  2. 4.1.1 Logistics & Distribution
  3. 4.1.2 Manufacturing and Packaging
  4. 4.1.3 Supply Chain Management
  5. 4.1.4 Other
  6. 4.2 Global Clinical Trial Supplies Sales Value by Type
  7. 4.2.1 Global Clinical Trial Supplies Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Clinical Trial Supplies Sales Value by Type (2021-2032)
  9. 4.2.3 Global Clinical Trial Supplies Sales Value Share by Type (2021-2032)
5 Clinical Trial Supplies Market by Application
  1. 5.1 Clinical Trial Supplies Application Introduction
  2. 5.1.1 Phase I
  3. 5.1.2 Phase II
  4. 5.1.3 Phase III
  5. 5.1.4 Other
  6. 5.2 Global Clinical Trial Supplies Sales Value by Application
  7. 5.2.1 Global Clinical Trial Supplies Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Clinical Trial Supplies Sales Value by Application (2021-2032)
  9. 5.2.3 Global Clinical Trial Supplies Sales Value Share by Application (2021-2032)
6 Clinical Trial Supplies Regional Value Analysis
  1. 6.1 Global Clinical Trial Supplies Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Clinical Trial Supplies Sales Value by Region (2021-2032)
  3. 6.2.1 Global Clinical Trial Supplies Sales Value by Region: 2021-2026
  4. 6.2.2 Global Clinical Trial Supplies Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Clinical Trial Supplies Sales Value (2021-2032)
  7. 6.3.2 North America Clinical Trial Supplies Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Clinical Trial Supplies Sales Value (2021-2032)
  10. 6.4.2 Europe Clinical Trial Supplies Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Clinical Trial Supplies Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Clinical Trial Supplies Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Clinical Trial Supplies Sales Value (2021-2032)
  16. 6.6.2 South America Clinical Trial Supplies Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Clinical Trial Supplies Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Clinical Trial Supplies Sales Value Share by Country, 2025 VS 2032
7 Clinical Trial Supplies Country-level Value Analysis
  1. 7.1 Global Clinical Trial Supplies Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Clinical Trial Supplies Sales Value by Country (2021-2032)
  3. 7.2.1 Global Clinical Trial Supplies Sales Value by Country (2021-2026)
  4. 7.2.2 Global Clinical Trial Supplies Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Clinical Trial Supplies Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Clinical Trial Supplies Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Clinical Trial Supplies Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Clinical Trial Supplies Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Catalent Pharma Solutions
  8. 8.2.1 Catalent Pharma Solutions Company Information
  9. 8.2.2 Catalent Pharma Solutions Business Overview
  10. 8.2.3 Catalent Pharma Solutions Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Catalent Pharma Solutions Clinical Trial Supplies Product Portfolio
  12. 8.2.5 Catalent Pharma Solutions Recent Developments
  13. 8.3 Almac Group
  14. 8.3.1 Almac Group Company Information
  15. 8.3.2 Almac Group Business Overview
  16. 8.3.3 Almac Group Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Almac Group Clinical Trial Supplies Product Portfolio
  18. 8.3.5 Almac Group Recent Developments
  19. 8.4 Parexel International
  20. 8.4.1 Parexel International Company Information
  21. 8.4.2 Parexel International Business Overview
  22. 8.4.3 Parexel International Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Parexel International Clinical Trial Supplies Product Portfolio
  24. 8.4.5 Parexel International Recent Developments
  25. 8.5 UDG Healthcare
  26. 8.5.1 UDG Healthcare Company Information
  27. 8.5.2 UDG Healthcare Business Overview
  28. 8.5.3 UDG Healthcare Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UDG Healthcare Clinical Trial Supplies Product Portfolio
  30. 8.5.5 UDG Healthcare Recent Developments
  31. 8.6 PCI Services
  32. 8.6.1 PCI Services Company Information
  33. 8.6.2 PCI Services Business Overview
  34. 8.6.3 PCI Services Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PCI Services Clinical Trial Supplies Product Portfolio
  36. 8.6.5 PCI Services Recent Developments
  37. 8.7 Marken
  38. 8.7.1 Marken Company Information
  39. 8.7.2 Marken Business Overview
  40. 8.7.3 Marken Clinical Trial Supplies Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Marken Clinical Trial Supplies Product Portfolio
  42. 8.7.5 Marken Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst